Page last updated: 2024-08-24

tenofovir and Cognitive Dysfunction

tenofovir has been researched along with Cognitive Dysfunction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Abboussi, O; Daniels, WMU; Mabandla, MV; Simola, N; Zulu, SS1
Alagaratnam, J; Boffito, M; Bozzali, M; Cercignani, M; Mora-Peris, B; Nelson, M; Toniolo, S; Underwood, J; Vera, JH; Winston, A1
Arendt, G; Orhan, E; Schlonies, S; Stüve, O1

Other Studies

3 other study(ies) available for tenofovir and Cognitive Dysfunction

ArticleYear
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice.
    Acta neuropsychiatrica, 2020, Volume: 32, Issue:5

    Topics: Administration, Oral; AIDS Dementia Complex; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Anti-HIV Agents; Aspartic Acid Endopeptidases; Brain; Cognitive Dysfunction; Disease Models, Animal; Female; Hippocampus; HIV Infections; HIV-1; Learning Disabilities; Lipid Peroxidation; Maze Learning; Memory; Mice; Mice, Inbred BALB C; Nevirapine; Tenofovir

2020
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
    Journal of neurovirology, 2020, Volume: 26, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asymptomatic Diseases; Benzoxazines; Cognitive Dysfunction; Connectome; Cyclopropanes; Drug Substitution; Emtricitabine; Executive Function; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxazines; Piperazines; Prospective Studies; Pyridones; Raltegravir Potassium; Rilpivirine; Tenofovir

2020
Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.
    Journal of neurovirology, 2019, Volume: 25, Issue:2

    Topics: Adult; Aging; Antiretroviral Therapy, Highly Active; Brain; Cognition; Cognitive Dysfunction; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir

2019